NYSE · Healthcare · Statistics
Valuation, profitability, balance-sheet health, and risk metrics for LLY — every field resolved through TECHi's unified provider chain (Yahoo + FMP fundamentals, Alpha Vantage and Twelve Data as deep fallbacks) and labelled with the winning source.
Valuation read
A trailing P/E above 30 means the market is paying up for LLY. That premium has to be earned with above-average revenue or earnings growth — pair this with the forward P/E (—) and the PEG ratio (—) before forming a view.
Frequently asked
Eli Lilly & Co. (LLY) has a market capitalization of $845.8 billion, computed from the latest share count and the live LLY quote price on TECHi.
LLY trades at a trailing P/E of 33.67. Forward P/E and PEG are visible alongside on the Statistics page; compare to the sector cohort on /quote/LLY/peers/.
Each metric on the LLY Statistics page is resolved through TECHi's unified-fundamentals layer — Yahoo and FMP primary, Alpha Vantage and Twelve Data as deep fallbacks — and labelled with the winning provider so you can verify any number.
Live quote-derived stats (52-week range, current ratio, beta) refresh every market session; reported fundamentals (margins, ROE, debt-to-equity) update each time the issuer files a new statement.